News

Introducing our new Pharmaceutical Director

We are delighted to welcome Dr Gerry Kenna to Safer Medicines Trust, and look forward to him continuing to innovate and forge a route to improved safety of medicines, through human-relevant methods. 
 Dr Gerry Kenna is a Drug Safety Consultant and a leading figure in the field of human drug induced liver injury.  Following his initial scientific training in biochemistry, at the Universities of Leeds (BSc Hons) and London (PhD), Dr Kenna established and led academic research teams which, for 19 years, studied the mechanisms by which medicines and other chemicals may damage cells of the liver.   He then moved to industry (at Zeneca, Syngenta and AstraZeneca), where for 14 years he used his expertise to support human safety assessment of new medicines and agrochemicals.  During this time, he also led research teams which developed improved human safety testing methods.  These used human tissues and did not require use of animals.  Dr Kenna is committed to ensuring that such human-relevant approaches are used routinely, by scientists in industry and in regulatory agencies, to aid the invention and development of safe new medicines.
Share
Follow Us

Latest Blog Posts

World Patient Safety Day – Medication Without Harm

  World Patient Safety Day is grounded in the most fundamental principle of medicine – first do no harm  “Medication Safety” is the theme for World Patient Safety Day 2022. Safer Medicines Trust is a patient safety charity whose mission is to improve the safety of medicines, so we very much support calls for “Medication Without Harm”. The World […]

The crisis of Alzheimer’s disease research: it’s time to embrace a new approach to help patients

The problem Alzheimer’s disease (AD) is a leading cause of death in the UK and along with other dementias, is responsible for almost 11% of all deaths in England.1 More than 209,000 new cases are diagnosed each year across the UK.2 It remains a leading cause of death and disability worldwide3, affecting nearly 50 million […]